TransMedics (TMDX) Revenue (2018 - 2026)

TransMedics has reported Revenue for 9 years, with the latest figure at $189.9 million in Q2 2026.

• On a quarterly basis, Revenue rose 20.7% year-over-year to $189.9 million in Q2 2026; TTM through Jun 2026 was $668.5 million, a 25.82% increase from a year earlier, with the FY2025 full-year figure at $605.5 million, up 37.13% from the prior year.
• Revenue was $189.9 million for Q2 2026 at TransMedics, up from $173.9 million in the prior quarter.
• The five-year high for Revenue was $189.9 million in Q2 2026, with the low at $15.9 million in Q1 2022.
• Average Revenue over 5 years is $97.0 million, with a median of $102.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Revenue surged 374.47% in 2022, then advanced 20.7% in 2026.
• Over 5 years, Revenue stood at $31.4 million in 2022, then surged by 158.72% to $81.2 million in 2023, then jumped by 49.83% to $121.6 million in 2024, then surged by 32.18% to $160.8 million in 2025, then rose by 18.15% to $189.9 million in 2026.
• The last three Revenue figures came in at $189.9 million (Q2 2026), $173.9 million (Q1 2026), and $160.8 million (Q4 2025), per Business Quant data.